Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971: a report from the Children's Oncology Group.
Cancer
; 118(19): 4806-14, 2012 Oct 01.
Article
in En
| MEDLINE
| ID: mdl-22392565
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Leukemia, Myeloid
/
Down Syndrome
Type of study:
Clinical_trials
/
Risk_factors_studies
Limits:
Adolescent
/
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
Language:
En
Journal:
Cancer
Year:
2012
Document type:
Article
Affiliation country:
United States
Country of publication:
United States